BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/08/2024

FDA Clears DELATESTRYL for Continued Sale

The US Food and Drug Administration (FDA) has ruled that DELATESTRYL (Testosterone Enanthate) Injection, 200 milligrams per milliliter, and other related drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing them to continue being approved for use in abbreviated new drug applications (ANDAs).

Source: Federal Register — Food and Drug AdministrationOpen original release →